NDC 0338-9632-01 - Zosyn
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0338-9632
- Requested NDC
- 0338-9632-01
- Package NDCs from labels
- 0338-9632-01, 0338-9632-24
- Manufacturer
- Baxter Healthcare Corporation
- Effective date
- 2026-05-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Zosyn - Baxter Healthcare Corporation | Baxter Healthcare Corporation | 2026-05-15 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0338-9632-01 | Zosyn | 50 mL in 1 BAG | INJECTION, SOLUTION | 50 | 6 | |
| 0338-9632-24 | Zosyn | 24 in 1 CARTON | INJECTION, SOLUTION | 24 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0338-9632-01 | ML - Milliliter | 0338-9632 | ca93780b-b5d8-4a16-99c2-9deb9652eea6 | 1 | 2023-05-05 |
| 0338-9632-24 | ML - Milliliter | 0338-9632 | 5b08da5a-ee9a-4754-928a-b2decf362dd2 | 1 | 2023-05-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OHTAS ISAN ANTACID | CALCIUM CARBONATE, SODIUM BICARBONATE | OHTA'S ISAN CO.,LTD. | 53380470-5748-6fa7-548e-7484ef204c0f | 2024-10-21 | Warnings | 8MDF5V39QO |
| OHTAS ISAN ANTACID | CALCIUM CARBONATE, SODIUM BICARBONATE | OHTA'S ISAN CO.,LTD. | 8723fe90-8402-4511-b6c6-b71cf98513e3 | 2024-10-21 | Warnings | 8MDF5V39QO |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Shandong Anxin Pharmaceutical Co., Ltd. | 420196a5-f62d-473f-84d8-d7fc3f31c3d3 | 2024-10-17 | Warnings, Adverse reactions | 1659137 1659131 1659149 M98T69Q7HP UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN SODIUM,TAZOBACTAM SODIUM | Fresenius Kabi USA, LLC | fc4d1e35-23eb-4654-8691-ae5bfd50a48a | 2024-10-16 | Warnings, Adverse reactions | 1659137 1659131 1659149 M98T69Q7HP UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Fresenius Kabi USA, LLC | e53ebafc-3afa-4a1e-9313-fecd1c1c5d7c | 2024-10-16 | Boxed warning, Warnings, Adverse reactions | M98T69Q7HP UXA545ABTT |
| Elliotts B | SODIUM CATION, SODIUM BICARBONATE, ANHYDROUS DEXTROSE, MAGNESIUM SULFATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM PHOSPHATE | Lukare Medical, LLC | 08036dbd-55b3-47b9-9890-000f253544f3 | 2024-10-16 | Warnings, Adverse reactions | 8MDF5V39QO |
| Piperacillin and Tazobactam | PIPERACILLIN SODIUM,TAZOBACTAM SODIUM | Fresenius Kabi USA, LLC | ba87ade3-4d41-40c0-9f6a-27e121a4136d | 2024-10-16 | Warnings, Adverse reactions | 1659137 1659131 1659149 M98T69Q7HP UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Fresenius Kabi USA, LLC | 2cfa6723-175b-4c4d-8212-266844b07610 | 2024-10-16 | Boxed warning, Warnings, Adverse reactions | M98T69Q7HP UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Fresenius Kabi USA, LLC | c78e0931-ec79-58e5-8658-7fe692dc3b8b | 2024-10-16 | Boxed warning, Warnings, Adverse reactions | M98T69Q7HP UXA545ABTT |
| EyS Eye Wash | WATER | Eyes-Plus LLC | 1443f6bf-3a77-4a19-8585-0ec58efe042f | 2024-10-15 | Warnings | 059QF0KO0R |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Apotex Corp. | c18109cf-d5db-4cc1-83da-537c8ab0e05c | 2024-10-14 | Warnings, Adverse reactions | M98T69Q7HP UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Shandong Anxin Pharmaceutical Co., Ltd. | f817b9be-b12b-48ac-8e4e-57ef6812eb32 | 2024-10-14 | Warnings, Adverse reactions | M98T69Q7HP UXA545ABTT |
| Eye Wash | WATER SOLUTION | Kroger Company | 354402ad-581d-47e7-9fd3-933bef281ff4 | 2024-10-11 | Warnings | 059QF0KO0R |
| Eye Wash | WATER | Hubei Changjian Medical Products Co., Ltd. | d57e1c5b-1edc-4a94-88bc-f9ecf347b7ea | 2024-10-11 | Warnings | 059QF0KO0R |
| teruflex blood bag system with diversion blood sampling arm 70 ml cpda-1 | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 86b3a329-c83f-4977-92f5-0e9dfe1872d7 | 2024-10-10 | Warnings | LX22YL083G |
| TERUFLEX BLOOD with Diversion Blood Sampling Arm 70 mL CPDA-1 | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 39f2e11c-5a31-469f-b725-d096c1674421 | 2024-10-03 | Warnings | LX22YL083G |
| piperacillin and tazobactam | PIPERACILLIN AND TAZOBACTAM | Armas Pharmaceuticals Inc. | 24d9b4f1-109c-4db4-8a99-03afff045b47 | 2024-09-27 | Warnings, Adverse reactions | 1659137 M98T69Q7HP UXA545ABTT |
| piperacillin and tazobactam | PIPERACILLIN AND TAZOBACTAM | Armas Pharmaceuticals Inc. | bbd1e6ae-e19a-4572-a0ec-e78c8aa31d2a | 2024-09-27 | Warnings, Adverse reactions | 1659149 M98T69Q7HP UXA545ABTT |
| SODIUM BICARBONATE | SODIUM BICARBONATE INJECTION, | Long Grove Pharmaceuticals, LLC | a26d709b-b294-4b02-9a88-7e840f099a33 | 2024-09-25 | Warnings, Adverse reactions | 8MDF5V39QO |
| TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 02015040-9b71-4dbe-8f8d-e0d0951e8f93 | 2024-09-19 | Warnings | LX22YL083G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.